Attralus lands Series A
South San Francisco-based Attralus, a biopharmaceutical company focused, has raised $25 million in Series A financing.
14 September 2020•1 min read
South San Francisco-based Attralus, a biopharmaceutical company focused, has raised $25 million in Series A financing.